Denne informasjonen er utarbeidet av IG, forretningsnavnet til IG Markets Limited. I tillegg til disclaimeren nedenfor, inneholder ikke denne siden oversikt over kurser, eller tilbud om, eller oppfordring til, en transaksjon i noe finansielt instrument. IG påtar seg intet ansvar for handlinger basert på disse kommentarene og for eventuelle konsekvenser som et resultat av dette. Ingen garanti gis for nøyaktigheten eller fullstendigheten av denne informasjonen. Personer som handler ut i fra denne informasjonen gjør det på egen risiko. Forskning gitt her tar ikke hensyn til spesifikke investeringsmål, finansiell situasjon og behov som angår den enkelte person som mottar dette. Denne informasjonen er ikke utarbeidet i samsvar med regelverket for investeringsanalyser, så derfor er denne informasjonen ansett å være markedsføringsmateriale. Selv om vi ikke er hindret i å handle i forkant av våre anbefalinger, ønsker vi ikke å dra nytte av dem før de blir levert til våre kunder. Se fullstendig disclaimer og kvartalsvis oppsummering.
In May 2015, Tate & Lyle announced an 82% fall in annual profits, and it wasn’t out of the blue as the firm has issued several profit warnings in recent history. The bulk ingredients business and the Splenda sucralose operation were the main sources of Tate & Lyles poor performance throughout the year. This has resulted in reorganising the Splenda sucralose business and exiting the bulk ingredients division in Europe. The CEO, Javed Ahmed, stated the year was ‘very challenging’, and the company is now going to concentrate on the food business.
When the restructuring costs were accounted, for the group’s profits fell to £51 million in comparison with £277 million the previous year. Tate & Lyle’s issues have not been a secret, and until the company can turn a corner and map out a clear plan for the future it will find it difficult to gain shareholder confidence.
Tougher competition in the sweetener market equated a massive fall in profits in the Splenda sucralose operation. The bulk ingredients division also had a poor performance
Tate & Lyle reports its first-half results on 5 November, and the market is expecting profit of £84 million and revenue of £1.38 billion, and that compares with first-half revenue and net adjusted income of £1.15 billion and £95 million respectively. The firm will announce its full-year figures in May 2016, and dealers are anticipating revenue of £2.59 billion and net adjusted income of £161 million. These forecasts represent a 10% jump in revenue and an 8.5% fall in adjusted net income.
Equity analysts are moderately bullish on Tate & Lyle, and out of the 17 ratings, six are buys, nine are holds, and two sells. The average target price is £6.12, which is 4% above the current price.
The stock has been slipping since July 2013, and the August low of 492p is the target. The stock has traded higher throughout September and should this continue the £6.30 will be the next level to watch. For over two years the stock has printed a set of lower lows and highs, and I will remain bearish will the stock is under 666p.